School of Public Health Dean Shawn Gibbs has led national and international research, training and policy related to responses to highly infectious diseases.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
Contract tracers linked many of the reported new cases to off-campus social gatherings.
The new self-collected saliva test takes less than five minutes and is critical to keeping in-person classes and activities.
Funding from a National Science Foundation program will help a team of Texas A&M engineering and public health students take the EASYMASK from concept to market.
The positivity rate for the week ending Oct. 10 was 1 percent.
Texas A&M experts say Dr. Anthony Fauci is right – holiday plans may have to change.
Texas A&M AgriLife Vice Chancellor Patrick Stover detailed nutrition problems and food supply disruption at a recent talk.
Texas A&M experts explain what states have learned so far.
Wenshe Ray Liu, the first scientist to identify remdesivir as a potential treatment option, says researchers are pursuing leads on medications to fight SARS-CoV-2.
The Department of Electrical and Computer Engineering at Texas A&M is modeling the spread of the virus on campus and across the state.
Texas A&M civil engineering researchers are using a deep learning model to forecast the growth of COVID-19 cases.